Targeting the Immune Checkpoint PTPN2 with ABBV-CLS-484 Inflames the Tumor Microenvironment and Unleashes Potent CD8+ T Cell Immunity
Arvin Iracheta-Vellve,Hakimeh Ebrahimi-Nik,Thomas R. Davis,Kira E. Olander,Sarah Y. Kim,Mitchell D. Yeary,James C. Patti,Ian C. Kohnle,Christina K. Baumgartner,Keith M. Hamel,Kathleen A. McGuire,Cun Lan Chuong,Zhaoming Xiong,Elliot P. Farney,Jennifer M. Frost,Matthew Rees,Andrew Boghossian,Melissa Ronan,Jennifer A. Roth,Todd R. Golub,Gabriel K. Griffin,Clay Beauregard,Philip R. Kym,Kathleen B. Yates,Robert T. Manguso Cancer Research（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper